{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:59:53Z","timestamp":1760385593806,"version":"3.41.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Pharmacol"],"published-print":{"date-parts":[[2000,12,1]]},"DOI":"10.1124\/mol.58.6.1451","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T20:40:58Z","timestamp":1515444058000},"page":"1451-1460","source":"Crossref","is-referenced-by-count":25,"title":["Interactions of Alcuronium, TMB-8, and Other Allosteric Ligands with Muscarinic Acetylcholine Receptors: Studies with Chimeric Receptors"],"prefix":"10.1016","volume":"58","author":[{"given":"John","family":"Ellis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Seidenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2000,12,1]]},"reference":[{"key":"2019092417245111000_58.6.1451.1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1476-5381.1979.tb08690.x","article-title":"The effects of ions on the binding of agonists and antagonists to muscarinic receptors.","volume":"67","author":"Birdsall","year":"1979","journal-title":"Br J Pharmacol"},{"key":"2019092417245111000_58.6.1451.2","doi-asserted-by":"publisher","DOI":"10.1042\/bst0230108"},{"key":"2019092417245111000_58.6.1451.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)00046-5"},{"key":"2019092417245111000_58.6.1451.4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0026-895X(25)09591-4","article-title":"Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.","volume":"38","author":"Bruns","year":"1990","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0031-6997(24)01362-0","article-title":"International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.","volume":"50","author":"Caulfield","year":"1998","journal-title":"Pharmacol Rev"},{"key":"2019092417245111000_58.6.1451.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1998.t01-4-.x"},{"key":"2019092417245111000_58.6.1451.7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0021-9258(17)31284-X","article-title":"Propylbenzilylcholine mustard labels an acidic residue in transmembrane helix 3 of the muscarinic receptor.","volume":"264","author":"Curtis","year":"1989","journal-title":"J Biol Chem"},{"key":"2019092417245111000_58.6.1451.8","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(86)90237-3"},{"key":"2019092417245111000_58.6.1451.9","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2299(199702)40:2<193::AID-DDR9>3.0.CO;2-G"},{"key":"2019092417245111000_58.6.1451.10","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90591-R"},{"key":"2019092417245111000_58.6.1451.11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0026-895X(25)09006-6","article-title":"Two allosteric modulators interact at a common site on cardiac muscarinic receptors.","volume":"42","author":"Ellis","year":"1992","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(98)00276-7"},{"key":"2019092417245111000_58.6.1451.13","doi-asserted-by":"publisher","DOI":"10.1159\/000028382"},{"key":"2019092417245111000_58.6.1451.14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0026-895X(25)13228-8","article-title":"Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.","volume":"44","author":"Ellis","year":"1993","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0026-895X(25)09700-7","article-title":"Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: Conserved aspartic acids play important roles in receptor function.","volume":"36","author":"Fraser","year":"1989","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.16","doi-asserted-by":"publisher","DOI":"10.1124\/mol.56.6.1245"},{"key":"2019092417245111000_58.6.1451.17","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0026-895X(25)09558-6","article-title":"Regulation of D2 dopamine receptors by amiloride and amiloride analogs.","volume":"50","author":"Hoare","year":"1996","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0026-895X(25)10154-5","article-title":"Localization of the ligand binding site of the neurokinin-1 receptor: Interpretation of chimeric mutations and single-residue substitutions.","volume":"45","author":"Huang","year":"1994","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0022-3565(25)10553-3","article-title":"Subtype selectivity of the positive allosteric action of alcuronium at cloned M1\u2013M5 muscarinic acetylcholine receptors.","volume":"274","author":"Jakubik","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"2019092417245111000_58.6.1451.20","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1046\/j.1471-4159.1994.63051932.x","article-title":"Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium.","volume":"63","author":"Jakubik","year":"1994","journal-title":"J Neurochem"},{"key":"2019092417245111000_58.6.1451.21","doi-asserted-by":"crossref","unstructured":"Jones SVP Levey AI Weiner DM Ellis J Novotny E Yu S-H Dorje F Wess J Brann MR (1992) Muscarinic Acetylcholine Receptors. in Molecular Biology of G-Protein-Coupled Receptors, ed Brann MR (Birkhauser, Boston), pp 170\u2013197.","DOI":"10.1007\/978-1-4684-6772-7_8"},{"key":"2019092417245111000_58.6.1451.22","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(96)10034-1"},{"key":"2019092417245111000_58.6.1451.23","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90703-8"},{"key":"2019092417245111000_58.6.1451.24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0022-3565(25)10752-0","article-title":"Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor.","volume":"262","author":"Lee","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"2019092417245111000_58.6.1451.25","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0026-895X(24)13259-2","article-title":"Characterization of the allosteric interactions between antagonists and amiloride analogues at the human alpha2A-adrenergic receptor.","volume":"53","author":"Leppik","year":"1998","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0026-895X(25)10214-9","article-title":"Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.","volume":"45","author":"Leppik","year":"1994","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0026-895X(25)08527-X","article-title":"Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.","volume":"47","author":"Matsui","year":"1995","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0773.1994.tb00380.x","article-title":"Allosteric effects of the alkane-bis-ammonium compound W84 and of tacrine on [3H]pirenzepine binding at M1-receptors in rat cerebral cortex.","volume":"75","author":"Mohr","year":"1994","journal-title":"Pharmacol Toxicol"},{"key":"2019092417245111000_58.6.1451.29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0026-895X(25)11432-6","article-title":"Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.","volume":"35","author":"Potter","year":"1989","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0026-895X(25)10157-0","article-title":"Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.","volume":"45","author":"Proska","year":"1994","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0026-895X(25)10523-3","article-title":"Competition between positive and negative allosteric effectors on muscarinic receptors.","volume":"48","author":"Proska","year":"1995","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1997.tb48147.x"},{"key":"2019092417245111000_58.6.1451.33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(25)21206-X","article-title":"Search for lead structures to develop new allosteric modulators of muscarinic receptors.","volume":"279","author":"Trankle","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"2019092417245111000_58.6.1451.34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0026-895X(25)09800-1","article-title":"Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.","volume":"46","author":"Waelbroeck","year":"1994","journal-title":"Mol Pharmacol"},{"key":"2019092417245111000_58.6.1451.35","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0022-3565(24)35223-1","article-title":"Binding, partial agonism, and potentiation of alpha(1)-adrenergic receptor function by benzodiazepines: A potential site of allosteric modulation.","volume":"291","author":"Waugh","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"2019092417245111000_58.6.1451.36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0026-895X(25)09481-7","article-title":"Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers.","volume":"38","author":"Wess","year":"1990","journal-title":"Mol Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.58.6.1451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T14:06:09Z","timestamp":1751205969000},"score":1,"resource":{"primary":{"URL":"http:\/\/molpharm.aspetjournals.org\/lookup\/doi\/10.1124\/mol.58.6.1451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12,1]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2000,12,1]]},"published-print":{"date-parts":[[2000,12,1]]}},"alternative-id":["10.1124\/mol.58.6.1451"],"URL":"https:\/\/doi.org\/10.1124\/mol.58.6.1451","relation":{},"ISSN":["0026-895X","1521-0111"],"issn-type":[{"type":"print","value":"0026-895X"},{"type":"electronic","value":"1521-0111"}],"subject":[],"published":{"date-parts":[[2000,12,1]]}}}